We are expanding our product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation Sequencing.Its unique combination of PCR amplification and parallel performed capillary electrophoresis enables the quantification of up to 2,000 DNA and RNA targets within 3.5 hours. Explore all the additional advantages it creates for your molecular diagnostics, either for customized development, routine use, or for technology transfer. ESMO 2019 Congress - European Society For Medical Oncology |
Biotype expands highly specific CE-IVD portfolio for chimerism monitoring. 56 Mentype® DIPquant assays are now CE-IVD-registered.Biotype GmbH, in response to customer demand, now offers the qPCR kit Mentype® DIPquant as an in-vitro diagnostic with European approval. It is the third CE-IVD approved assay for chimerism analysis, alongside Mentype® Chimera® and Mentype® DIPscreen, and it extends the chimerism portfolio for use in in vitro diagnostics. 28-06-2019 We are excited to announce that Biotype Diagnostic GmbH and Biotype Innovation GmbH have decided to merge their capabilities to form one strong entity.
|
